Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Cilostazol for primary prevention of stroke in peripheral artery disease: a population-based longitudinal study in Taiwan.

Lee WH, Chu CY, Hsu PC, Su HM, Lin TH, Voon WC, Lai WT, Sheu SH.

Thromb Res. 2013 Aug;132(2):190-5. doi: 10.1016/j.thromres.2013.01.036. Epub 2013 Feb 19.

PMID:
23433530
[PubMed - indexed for MEDLINE]
2.

Comparison of antiplatelet and antithrombotic therapy for secondary prevention of ischemic stroke in patients with peripheral artery disease: population-based follow-up study in Taiwan.

Lee WH, Chu CY, Hsu PC, Su HM, Lin TH, Voon WC, Lai WT, Sheu SH.

Circ J. 2013;77(4):1046-52. Epub 2012 Dec 26.

PMID:
23269006
[PubMed - indexed for MEDLINE]
Free Article
3.

Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin.

Kamal AK, Naqvi I, Husain MR, Khealani BA.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008076. doi: 10.1002/14651858.CD008076.pub2. Review.

PMID:
21249700
[PubMed - indexed for MEDLINE]
4.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.

Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review.

PMID:
21888837
[PubMed - indexed for MEDLINE]
Free Article
5.

Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.

Lee YS, Bae HJ, Kang DW, Lee SH, Yu K, Park JM, Cho YJ, Hong KS, Kim DE, Kwon SU, Lee KB, Rha JH, Koo J, Han MG, Lee SJ, Lee JH, Jung SW, Lee BC, Kim JS.

Cerebrovasc Dis. 2011;32(1):65-71. doi: 10.1159/000327036. Epub 2011 May 25.

PMID:
21613787
[PubMed - indexed for MEDLINE]
6.

Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study.

Huang Y, Cheng Y, Wu J, Li Y, Xu E, Hong Z, Li Z, Zhang W, Ding M, Gao X, Fan D, Zeng J, Wong K, Lu C, Xiao J, Yao C; Cilostazol versus Aspirin for Secondary Ischaemic Stroke Prevention cooperation investigators.

Lancet Neurol. 2008 Jun;7(6):494-9. doi: 10.1016/S1474-4422(08)70094-2. Epub 2008 May 2. Erratum in: Lancet Neurol. 2008 Aug;7(8):675.

PMID:
18456558
[PubMed - indexed for MEDLINE]
7.

Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis.

Malloy RJ, Kanaan AO, Silva MA, Donovan JL.

Clin Ther. 2013 Oct;35(10):1490-1500.e7. doi: 10.1016/j.clinthera.2013.09.004.

PMID:
24139421
[PubMed - indexed for MEDLINE]
8.

Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke.

Dinicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O'Keefe JH, Bangalore S, Messerli FH.

Am J Cardiol. 2013 Oct 15;112(8):1230-4. doi: 10.1016/j.amjcard.2013.05.067. Epub 2013 Jul 2. Review.

PMID:
23827403
[PubMed - indexed for MEDLINE]
9.

Systematic study of cilostazol on secondary stroke prevention: a meta-analysis.

Qian Y, Bi Q.

Eur J Med Res. 2013 Dec 6;18:53. doi: 10.1186/2047-783X-18-53.

PMID:
24313983
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study.

Han Y, Li Y, Wang S, Jing Q, Wang Z, Wang D, Shu Q, Tang X.

Am Heart J. 2009 Apr;157(4):733-9. doi: 10.1016/j.ahj.2009.01.006. Epub 2009 Mar 17.

PMID:
19332203
[PubMed - indexed for MEDLINE]
11.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

PMID:
15461876
[PubMed - indexed for MEDLINE]
Free Article
12.

[Results of the Cilostazol Stroke Prevention Study II (CSPS II): a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients].

Uchiyama S.

Rinsho Shinkeigaku. 2010 Nov;50(11):832-4. Review. Japanese.

PMID:
21921460
[PubMed - indexed for MEDLINE]
13.
14.

Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes.

Leeper NJ, Bauer-Mehren A, Iyer SV, Lependu P, Olson C, Shah NH.

PLoS One. 2013 May 23;8(5):e63499. doi: 10.1371/journal.pone.0063499. Print 2013.

PMID:
23717437
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status.

Capranzano P, Ferreiro JL, Ueno M, Capodanno D, Dharmashankar K, Darlington A, Desai B, Tello-Montoliu A, Rollini F, Angiolillo DJ.

Catheter Cardiovasc Interv. 2013 Jan 1;81(1):42-9. doi: 10.1002/ccd.24416. Epub 2012 Apr 17.

PMID:
22431415
[PubMed - indexed for MEDLINE]
16.

Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.

Suh JW, Lee SP, Park KW, Lee HY, Kang HJ, Koo BK, Cho YS, Youn TJ, Chae IH, Choi DJ, Rha SW, Bae JH, Kwon TG, Bae JW, Cho MC, Kim HS.

J Am Coll Cardiol. 2011 Jan 18;57(3):280-9. doi: 10.1016/j.jacc.2010.08.631.

PMID:
21232664
[PubMed - indexed for MEDLINE]
Free Article
17.

Effects of cilostazol on platelet activation in coronary stenting patients who already treated with aspirin and clopidogrel.

Ahn JC, Song WH, Kwon JA, Park CG, Seo HS, Oh DJ, Rho YM.

Korean J Intern Med. 2004 Dec;19(4):230-6.

PMID:
15683111
[PubMed - indexed for MEDLINE]
Free Article
18.

Clopidogrel resistance and the effect of combination cilostazol in patients with ischemic stroke or carotid artery stenting using the VerifyNow P2Y12 Assay.

Maruyama H, Takeda H, Dembo T, Nagoya H, Kato Y, Fukuoka T, Deguchi I, Horiuchi Y, Tanahashi N.

Intern Med. 2011;50(7):695-8. Epub 2011 Apr 1.

PMID:
21467700
[PubMed - indexed for MEDLINE]
Free Article
19.

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.

Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN.

Clin Ther. 2009 Sep;31(9):2038-47. doi: 10.1016/j.clinthera.2009.09.005.

PMID:
19843493
[PubMed - indexed for MEDLINE]
20.

Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects).

Hiatt WR, Money SR, Brass EP.

J Vasc Surg. 2008 Feb;47(2):330-336. Epub 2007 Dec 26.

PMID:
18155871
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk